L. Tomlinson

First name
L.
Middle name
A.
Last name
Tomlinson
Wilkinson, S. ., Williamson, E. ., Pokrajac, A. ., Fogarty, D. ., Stirnadel-Farrant, H. ., Smeeth, L. ., … Tomlinson, L. A. (2020). Comparative effects of sulfonylureas, DPP4is and SGLT2 inhibitors added to metformin monotherapy: a propensity-score matched cohort study in UK primary care. Diabetes Obes Metab. http://doi.org/10.1111/dom.13970
Hayes, J. F., Osborn, D. P. J., Francis, E. ., Ambler, G. ., Tomlinson, L. A., Boman, M. ., … Lewis, G. . (2021). Prediction of individuals at high risk of chronic kidney disease during treatment with lithium for bipolar disorder. BMC Med. http://doi.org/10.1186/s12916-021-01964-z
Brown, J. P., Tazare, J. R., Williamson, E. ., Mansfield, K. E., Evans, S. J., Tomlinson, L. A., … Douglas, I. J. (2021). Proton pump inhibitors and risk of all-cause and cause-specific mortality: a cohort study. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.14728
Bidulka, P. ., O\textquoterightNeill, S. ., Basu, A. ., Wilkinson, S. ., Silverwood, R. J., Charlton, P. ., … Grieve, R. . (2021). Protocol for an observational cohort study investigating personalised medicine for intensification of treatment in people with type 2 diabetes mellitus: the PERMIT study. BMJ Open. http://doi.org/10.1136/bmjopen-2020-046912